Multicenter Automated Central Vein Sign Detection Performs as Well as Manual Assessment for the Diagnosis of Multiple Sclerosis

References

1. 1.↵
   1. Solomon AJ,
   2. Arrambide G,
   3. Brownlee WJ, et al

   . Differential diagnosis of suspected multiple sclerosis: an updated consensus approach. Lancet Neurol 2023;22:750–68 doi:10.1016/S1474-4422(23)00148-5 pmid:37479377

   CrossRefPubMed
2. 2.↵
   1. Solomon AJ,
   2. Bourdette DN,
   3. Cross AH, et al

   . The contemporary spectrum of multiple sclerosis misdiagnosis: a multicenter study. Neurology 2016;87:1393–99 doi:10.1212/WNL.0000000000003152 pmid:27581217

   Abstract/FREE Full Text
3. 3.↵
   1. Fog T

   . On the vessel-plaque relationships in the brain in multiple sclerosis. Acta Neurol Scand Suppl 1963;39(4):258–62 doi:10.1111/j.1600-0404.1963.tb01841.x pmid:14057511

   CrossRefPubMed
4. 4.↵
   1. Sati P,
   2. Oh J,
   3. Constable RT

   ; NAIMS Cooperative, et al. The central vein sign and its clinical evaluation for the diagnosis of multiple sclerosis: a consensus statement from the North American Imaging in Multiple Sclerosis Cooperative. Nat Rev Neurol 2016;12:714–22 doi:10.1038/nrneurol.2016.166 pmid:27834394

   CrossRefPubMed
5. 5.↵
   1. George IC,
   2. Sati P,
   3. Absinta M, et al

   . Clinical 3-Tesla FLAIR* MRI improves diagnostic accuracy in multiple sclerosis. Mult Scler 2016;22:1578–86 doi:10.1177/1352458515624975 pmid:26769065

   CrossRefPubMed
6. 6.↵
   1. Suh CH,
   2. Kim SJ,
   3. Jung SC, et al

   . The “central vein sign” on T2*-weighted images as a diagnostic tool in multiple sclerosis: a systematic review and meta-analysis using individual patient data. Sci Rep 2019;9:18188 doi:10.1038/s41598-019-54583-3 pmid:31796822

   CrossRefPubMed
7. 7.↵
   1. Castellaro M,
   2. Tamanti A,
   3. Pisani AI, et al

   . The use of the central vein sign in the diagnosis of multiple sclerosis: a systematic review and meta-analysis. Diagnostics (Basel) 2020;10:1025 doi:10.3390/diagnostics10121025

   CrossRefPubMed
8. 8.↵
   1. Solomon AJ,
   2. Watts R,
   3. Ontaneda D, et al

   . Diagnostic performance of central vein sign for multiple sclerosis with a simplified three-lesion algorithm. Mult Scler 2018;24:750–57 doi:10.1177/1352458517726383 pmid:28820013

   CrossRefPubMed
9. 9.↵
   1. Campion T,
   2. Smith RJP,
   3. Altmann DR, et al

   . FLAIR* to visualize veins in white matter lesions: a new tool for the diagnosis of multiple sclerosis? Eur Radiology 2017;27:4257–63 doi:10.1007/s00330-017-4822-z pmid:28409356

   CrossRefPubMed
10. 10.↵
    1. Sinnecker T,
    2. Clarke MA,
    3. Meier D

    ; MAGNIMS Study Group, et al. Evaluation of the central vein sign as a diagnostic imaging biomarker in multiple sclerosis. JAMA Neurol 2019;76:1446–56 doi:10.1001/jamaneurol.2019.2478 pmid:31424490

    CrossRefPubMed
11. 11.↵
    1. Mistry N,
    2. Abdel-Fahim R,
    3. Samaraweera A, et al

    . Imaging central veins in brain lesions with 3-T T2*-weighted magnetic resonance imaging differentiates multiple sclerosis from microangiopathic brain lesions. Mult Scler 2016;22:1289–96 doi:10.1177/1352458515616700 pmid:26658816

    CrossRefPubMed
12. 12.↵
    1. Sati P,
    2. George IC,
    3. Shea CD, et al

    . FLAIR*: a combined MR contrast technique for visualizing white matter lesions and parenchymal veins. Radiology 2012;265:926–32 doi:10.1148/radiol.12120208 pmid:23074257

    CrossRefPubMedWeb of Science
13. 13.↵
    1. Ontaneda D,
    2. Sati P,
    3. Raza P

    ; North American Imaging in MS Cooperative, et al. Central vein sign: a diagnostic biomarker in multiple sclerosis (CAVS-MS) study protocol for a prospective multicenter trial. Neuroimage Clin 2021;32:102834 doi:10.1016/j.nicl.2021.102834 pmid:34592690

    CrossRefPubMed
14. 14.↵
    1. Dworkin J,
    2. Sati P,
    3. Solomon A, et al

    . Automated integration of multimodal MRI for the probabilistic detection of the central vein sign in white matter lesions. AJNR Am J Neuroradiol 2018;39:1806–13 doi:10.3174/ajnr.A5765 pmid:30213803

    Abstract/FREE Full Text
15. 15.↵
    1. Daboul L,
    2. O’Donnell CM,
    3. Cao Q, et al

    . Effect of GBCA use on detection and diagnostic performance of the central vein sign: evaluation using a 3-T FLAIR* sequence in patients with suspected multiple sclerosis. AJR Am J Roentgenol 2023;220:115–25 doi:10.2214/AJR.22.27731 pmid:35975888

    CrossRefPubMed
16. 16.↵
    1. Daboul L,
    2. O’Donnell CM,
    3. Amin M, et al

    . A multicenter pilot study evaluating simplified central vein assessment for the diagnosis of multiple sclerosis. Mult Scler 2024;30:25–34 doi:10.1177/13524585231214360 pmid:38088067

    CrossRefPubMed
17. 17.↵
    1. Valcarcel AM,
    2. Linn KA,
    3. Khalid F, et al

    . A dual modeling approach to automatic segmentation of cerebral T2 hyperintensities and T1 black holes in multiple sclerosis. Neuroimage Clin 2018;20:1211–21 doi:10.1016/j.nicl.2018.10.013 pmid:30391859

    CrossRefPubMed
18. 18.↵
    1. Valcarcel AM,
    2. Linn KA,
    3. Vandekar SN, et al

    . MIMoSA: an automated method for intermodal segmentation analysis of multiple sclerosis brain lesions. J Neuroimaging 2018;28:389–98 doi:10.1111/jon.12506 pmid:29516669

    CrossRefPubMed
19. 19.↵
    1. Dworkin JD,
    2. Linn KA,
    3. Oguz I

    ; North American Imaging in Multiple Sclerosis Cooperative, et al. An automated statistical technique for counting distinct multiple sclerosis lesions. AJNR Am J Neuroradiol 2018;39:626–33 doi:10.3174/ajnr.A5556 pmid:29472300

    Abstract/FREE Full Text
20. 20.↵
    1. Wells WM,
    2. Colchester A,
    3. Delp S

    1. Frangi AF,
    2. Niessen WJ,
    3. Vincken KL, et al

    . Multiscale vessel enhancement filtering. In: Wells WM, Colchester A, Delp S, eds. Proceedings of Medical Image Computing and Computer-Assisted Intervention (MICCAI’98); October 11–18, 1998; Cambridge, Massachusetts. Springer.
21. 21.↵
    1. Robin X,
    2. Turck N,
    3. Hainard A, et al

    . pROC: an open-source package for R and S+ to analyze and compare ROC curves. BMC Bioinformatics 2011;12:77 doi:10.1186/1471-2105-12-77 pmid:21414208

    CrossRefPubMed
22. 22.↵
    1. Kurtzke JF

    . Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS). Neurology 1983;33:1444–52 doi:10.1212/wnl.33.11.1444 pmid:6685237

    Abstract/FREE Full Text
23. 23.↵
    1. Maggi P,
    2. Fartaria MJ,
    3. Jorge J, et al

    . CVSnet: a machine learning approach for automated central vein sign assessment in multiple sclerosis. NMR Biomed 2020;33:e4283 doi:10.1002/nbm.4283 pmid:32125737

    CrossRefPubMed
24. 24.↵
    1. Ontaneda D,
    2. Cohen JA,
    3. Sati P

    . Incorporating the central vein sign into the diagnostic criteria for multiple sclerosis. JAMA Neurol 2023;80:657–58 doi:10.1001/jamaneurol.2023.0717 pmid:37067820

    CrossRefPubMed
25. 25.↵
    1. Levasseur VA,
    2. Xiang B,
    3. Salter A, et al

    . Stronger microstructural damage revealed in multiple sclerosis lesions with central vein sign by quantitative gradient echo MRI. J Cent Nerv Syst Dis 2022;14:11795735221084842 doi:10.1177/11795735221084842 pmid:35370433

    CrossRefPubMed
26. 26.↵
    1. Zhang X,
    2. Lin D,
    3. Pforsich H, et al

    . Physician workforce in the United States of America: forecasting nationwide shortages. Hum Resour Health 2020;18:8 doi:10.1186/s12960-020-0448-3 pmid:32029001

    CrossRefPubMed
27. 27.↵
    1. Abou Mrad T,
    2. Naja K,
    3. Khoury SJ, et al

    . Central vein sign and paramagnetic rim sign: from radiologically isolated syndrome to multiple sclerosis. Eur J Neurol 2023;30:2912–18 doi:10.1111/ene.15922 pmid:37350369

    CrossRefPubMed
28. 28.↵
    1. Kister I,
    2. Herbert J,
    3. Zhou Y, et al

    . Ultrahigh-field MR (7 T) imaging of brain lesions in neuromyelitis optica. Mult Scler Int 2013;2013:398259 doi:10.1155/2013/398259 pmid:23431447

    CrossRefPubMed
29. 29.↵
    1. Massacesi L

    . Evaluation by brain MRI of white matter perivenular lesions in inflammatory microangiopathic ischemia and in demyelinating multiple sclerosis lesions [abstract O2217]. Eur J Neurol 2016;23:86
30. 30.↵
    1. Lummel N,
    2. Boeckh-Behrens T,
    3. Schoepf V, et al

    . Presence of a central vein within white matter lesions on susceptibility weighted imaging: a specific finding for multiple sclerosis? Neuroradiology 2011;53:311–17 doi:10.1007/s00234-010-0736-z pmid:20585764

    CrossRefPubMed
31. 31.↵
    1. Wuerfel J,
    2. Sinnecker T,
    3. Ringelstein EB, et al

    . Lesion morphology at 7 Tesla MRI differentiates Susac syndrome from multiple sclerosis. Mult Scler 2012;18:1592–99 doi:10.1177/1352458512441270 pmid:22711711

    CrossRefPubMed
32. 32.↵
    1. Solomon AJ,
    2. Schindler MK,
    3. Howard DB, et al

    . Central vessel sign on 3T FLAIR* MRI for the differentiation of multiple sclerosis from migraine. Ann Clin Transl Neurol 2016;3:82–87 doi:10.1002/acn3.273 pmid:26900578

    CrossRefPubMed